Imprivata has acquired a division of Caradigm, a GE Healthcare company that will now specialize in analytics and population health management.
Under the deal, healthcare IT firm Imprivata will add to its business Caradigm's identity and access management solutions. Those include single sign-on, multifactor authentication, and other risk-management and governance applications that more than 100 healthcare organizations around the world use.
In addition to a biometrics-based patient ID, Imprivata already offers security and identity technology, including single sign-on and multifactor authentication. That overlap won't be a problem for now, said Imprivata CEO Gus Malezis. Imprivata will support customers across the board for the time being, he said.
"We're completely committed to our Caradigm customers, and we're going to support their technology and investments," he said. "Over time, we're going to come up with an integrated solution that brings the best of the two worlds together and adds even more capabilities."
Caradigm also adds new technologies to Imprivata's portfolio, including context management, which helps reduce clicks by pointing a physician to the same patient across systems.
GE Healthcare and Microsoft launched Caradigm in 2012, and in 2016, Microsoft sold its 50% stake in the company to GE Healthcare.
"We've had a working relationship with GE Healthcare for a number of years," Malezis said. "This allows us to expand that relationship and to come to a harmonized solution."